These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34265357)

  • 1. A radiomic signature model to predict the chemoradiation-induced alteration in tumor-infiltrating CD8
    Jeon SH; Lim YJ; Koh J; Chang WI; Kim S; Kim K; Chie EK
    Radiother Oncol; 2021 Sep; 162():124-131. PubMed ID: 34265357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiomic features derived from pretherapeutic MRI predict chemoradiation response in locally advanced rectal cancer.
    Chou Y; Peng SH; Lin HY; Lan TL; Jiang JK; Liang WY; Hu YW; Wang LW
    J Chin Med Assoc; 2023 Apr; 86(4):399-408. PubMed ID: 36727777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Cui Y; Yang X; Shi Z; Yang Z; Du X; Zhao Z; Cheng X
    Eur Radiol; 2019 Mar; 29(3):1211-1220. PubMed ID: 30128616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
    Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
    Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8+ and FOXP3+ tumor-infiltrating T cells before and after chemoradiotherapy for rectal cancer.
    Shinto E; Hase K; Hashiguchi Y; Sekizawa A; Ueno H; Shikina A; Kajiwara Y; Kobayashi H; Ishiguro M; Yamamoto J
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S414-21. PubMed ID: 24566864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of an MRI-based radiomic nomogram to distinguish between good and poor responders in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy.
    Wang J; Liu X; Hu B; Gao Y; Chen J; Li J
    Abdom Radiol (NY); 2021 May; 46(5):1805-1815. PubMed ID: 33151359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI Radiomics Model Predicts Pathologic Complete Response of Rectal Cancer Following Chemoradiotherapy.
    Shin J; Seo N; Baek SE; Son NH; Lim JS; Kim NK; Koom WS; Kim S
    Radiology; 2022 May; 303(2):351-358. PubMed ID: 35133200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiomic Features of Primary Rectal Cancers on Baseline T
    Antunes JT; Ofshteyn A; Bera K; Wang EY; Brady JT; Willis JE; Friedman KA; Marderstein EL; Kalady MF; Stein SL; Purysko AS; Paspulati R; Gollamudi J; Madabhushi A; Viswanath SE
    J Magn Reson Imaging; 2020 Nov; 52(5):1531-1541. PubMed ID: 32216127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiomics Analysis for Evaluation of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
    Liu Z; Zhang XY; Shi YJ; Wang L; Zhu HT; Tang Z; Wang S; Li XT; Tian J; Sun YS
    Clin Cancer Res; 2017 Dec; 23(23):7253-7262. PubMed ID: 28939744
    [No Abstract]   [Full Text] [Related]  

  • 10. Systemic Inflammatory Markers Combined with Tumor-Infiltrating Lymphocyte Density for the Improved Prediction of Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer.
    Sawada R; Akiyoshi T; Kitagawa Y; Hiyoshi Y; Mukai T; Nagasaki T; Yamaguchi T; Konishi T; Yamamoto N; Ueno M; Fukunaga Y
    Ann Surg Oncol; 2021 Oct; 28(11):6189-6198. PubMed ID: 33876358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer.
    Zhuang Z; Liu Z; Li J; Wang X; Xie P; Xiong F; Hu J; Meng X; Huang M; Deng Y; Lan P; Yu H; Luo Y
    J Transl Med; 2021 Jun; 19(1):256. PubMed ID: 34112180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomics-Based Pretherapeutic Prediction of Non-response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
    Zhou X; Yi Y; Liu Z; Cao W; Lai B; Sun K; Li L; Zhou Z; Feng Y; Tian J
    Ann Surg Oncol; 2019 Jun; 26(6):1676-1684. PubMed ID: 30887373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoradiation-Induced Alteration of Programmed Death-Ligand 1 and CD8
    Lim YJ; Koh J; Kim S; Jeon SR; Chie EK; Kim K; Kang GH; Han SW; Kim TY; Jeong SY; Park KJ; Wu HG
    Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1216-1224. PubMed ID: 29165286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell complexity and density are associated with sensitivity to neoadjuvant chemoradiotherapy in patients with rectal cancer.
    Akiyoshi T; Gotoh O; Tanaka N; Kiyotani K; Yamamoto N; Ueno M; Fukunaga Y; Mori S
    Cancer Immunol Immunother; 2021 Feb; 70(2):509-518. PubMed ID: 32845355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiomics of locally advanced rectal cancer: machine learning-based prediction of response to neoadjuvant chemoradiotherapy using pre-treatment sagittal T2-weighted MRI.
    Yardimci AH; Kocak B; Sel I; Bulut H; Bektas CT; Cin M; Dursun N; Bektas H; Mermut O; Yardimci VH; Kilickesmez O
    Jpn J Radiol; 2023 Jan; 41(1):71-82. PubMed ID: 35962933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multiple-time-scale comparative study for the added value of magnetic resonance imaging-based radiomics in predicting pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Peng W; Wan L; Wang S; Zou S; Zhao X; Zhang H
    Front Oncol; 2023; 13():1234619. PubMed ID: 37664046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenomic profiles associated with response to neoadjuvant chemoradiotherapy in patients with rectal cancer.
    Akiyoshi T; Tanaka N; Kiyotani K; Gotoh O; Yamamoto N; Oba K; Fukunaga Y; Ueno M; Mori S
    Br J Surg; 2019 Sep; 106(10):1381-1392. PubMed ID: 31197828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of tumor-infiltrating lymphocytes before and after neoadjuvant therapy for rectal cancer.
    Matsutani S; Shibutani M; Maeda K; Nagahara H; Fukuoka T; Nakao S; Hirakawa K; Ohira M
    Cancer Sci; 2018 Apr; 109(4):966-979. PubMed ID: 29464828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-infiltrating lymphocytes, forkhead box P3, programmed death ligand-1, and cytotoxic T lymphocyte-associated antigen-4 expressions before and after neoadjuvant chemoradiation in rectal cancer.
    Teng F; Meng X; Kong L; Mu D; Zhu H; Liu S; Zhang J; Yu J
    Transl Res; 2015 Dec; 166(6):721-732.e1. PubMed ID: 26209749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selecting Candidates for Organ-Preserving Strategies After Neoadjuvant Chemoradiotherapy for Rectal Cancer: Development and Validation of a Model Integrating MRI Radiomics and Pathomics.
    Wan L; Sun Z; Peng W; Wang S; Li J; Zhao Q; Wang S; Ouyang H; Zhao X; Zou S; Zhang H
    J Magn Reson Imaging; 2022 Oct; 56(4):1130-1142. PubMed ID: 35142001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.